Arch Therapeutics (QB) Stock Quote ARTHD - Stock Price, News, Charts, Message Board, Trades

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
USOTC
Arch Therapeutics Inc (QB) (ARTHD) Quote

Arch Therapeutics Inc (QB) (ARTHD)

3.60

0.00

(0.00%)

Closed July 27 4:00PM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

3.60

Bid

0.00

Ask

0.00

Volume

-

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

3.60

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

3,094,000

Dividend Yield

-

PE Ratio

-0.40

Earnings Per Share (EPS)

-2.26

Revenue

76k

Net Profit

-6.98M

Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform wit... Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch's products authorized for commercial marketing are AC5 Advanced Wound System and AC5 Topical Hemostat. Arch's development stage product candidates include AC5-GTM and AC5 Surgical Hemostat, among others. Show more

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

www.archtherapeutics.com

Headquarters

Carson City, Nevada, USA

Founded

1970

Arch Therapeutics Inc (QB) is listed in the Surgical,med Instr,apparatus sector of the OTCMarkets with ticker ARTHD. The last closing price for Arch Therapeutics (QB) was $3.60. Over the last year, Arch Therapeutics (QB) shares have traded in a share price range of $ 0.00 to $ 0.00.

Arch Therapeutics (QB) currently has 3,094,000 shares outstanding. The market capitalization of Arch Therapeutics (QB) is $11.14 million. Arch Therapeutics (QB) has a price to earnings ratio (PE ratio) of -0.40.

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	-2.36	-39.5973154362	5.96	7	3.01	1957	4.90424821	CS
260	-2.36	-39.5973154362	5.96	7	3.01	1957	4.90424821	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	260.07k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.61M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M

Preciouslife1

Preciouslife1 2 minutes ago

https://www.mlb.com/stats/

Konaploinks

Konaploinks 3 minutes ago

Next! Stick a fork in her. She’s done. Sorry Len. You’re on the wrong radical left lunatic Sad

PutzMueler

PutzMueler 3 minutes ago

yah Poor Dean Kehler

I think Mark should give him the opportunity to sell all his shares @ $5.00
Why hold onto that heavy burden of him having so much control hanging over Mark's Head!

I'm glad things worked out so well, for the rest of us though!!

surfer44

surfer44 4 minutes ago

Yes. I'll also buy an occasional call option for leverage and so I can use the money somewhere else. Sounds like you're on it.

rosemountbomber

rosemountbomber 5 minutes ago

Did realize that Jardiance and Spiriva are their drugs. Largest private pharmaceutical company.

OMOLIVES

OMOLIVES 5 minutes ago

Incorrect. It's never been easier to prepare taxes. The change was good....the loopholes need to be fixed. This is what I am talking about:

https://www.cnbc.com/2024/06/17/treasury-unveils-plan-to-close-tax-loophole-large-partnerships.html

That loophole is used by bo

Nebuchadnezzar

Nebuchadnezzar 5 minutes ago

DEADPOOL &WOLVERINE on FIRE!!!

huge cash $$$$$$$$$$$ for CNK AMC

https://deadline.com/tag/deadpool-wolverine/

Swampy83

Swampy83 5 minutes ago

No, I just had it. They never responded to my emails, so just went ahead and submitted a complaint to SEC. If form 10 is coming then they should be fine...

Welcome2Pinkyland

Welcome2Pinkyland 5 minutes ago

The otc is not what it was - but we are talking not about the state of the otc - butt rather about posters leaving Ihub to post elsewhere.

Nebuchadnezzar

Nebuchadnezzar 6 minutes ago

$AMC is in for wild ride

https://deadline.com/tag/deadpool-wolverine/

delerious1

delerious1 7 minutes ago

It is extremely unusual to have a stock discussion site that has a whole group of outspoken members that profess to be part of some organised outfit to protect new and old traders of OTC stocks. They even have boards dedicated to it
I have never seen that before on any stock site

oilin07

oilin07 9 minutes ago

Multiple pennies are coming. If you are not in this you will greatly regret it. Lofe changing.

delerious1

delerious1 10 minutes ago

Here we are.....times change and most people adjust, granted the OTC is not what it was but there are still many many opportunities to make money...after all there are over 10,000 stocks trading on the OTC....if that doesn't give you and others an opportunity .....

PEACHMAN

PEACHMAN 11 minutes ago

Let me be clear this beautiful Saturday night about IFUS.

The main reason right now that everyone should buy IFUS stock is that they discovered how to break down the lignin in Bagasse and create a new game changing cattle feed product that will change the world called SGP+

Codycrusher

Codycrusher 12 minutes ago

What’s up y’all, exciting things ahead for PTOP!

Konaploinks

Konaploinks 12 minutes ago

They’re a bunch of crooks. Any questions?

sentiment_stocks

sentiment_stocks 12 minutes ago

It’s your post instead that is misleading.

May 29, 2019
Northwest resolves billing issues with Cognate.

February 20, 2018
https://www.businesswire.com/news/home/20180220006077/en
Cognate is sold to the management team and other investors by LP.

oystersnbeer

oystersnbeer 12 minutes ago

Kamala and her supporters are smart ,
Donnie and his supporters are stupid,

The contrast is astounding.

nowwhat2

nowwhat2 13 minutes ago

Bitcoin under microscope
Gong Show under microscope

https://investorshub.advfn.com/uimage/uploads/2024/7/27/erpcgbtc_777_27_7d_zoom_645pm_SUMMARY_TRUMP.jpg

NEWS Before, During and After It Happens

https://investorshub.advfn.com/uimage/upl

janice shell

janice shell 14 minutes ago

No, it did not. It had everything to do with the SEC. First, in 2013 it took down the enormously popular Awesome Penny Stocks promotional group. In the past, new promoters popped up to replacer the ones the enforcement agencies very occasionally went after. But this time, the SEC methodically pursue

delerious1

delerious1 14 minutes ago

It's a shame so many left iHub lately....and so avoidable

chipboarder

chipboarder 15 minutes ago

So we are about 2 weeks from the Q2 Earnings Report and it’s fun to speculate…we know that the rental income will be about $133k (from the Qi-10Q) and we know that we have slightly more than $22 million in interest bearing investments (assuming an annual rate of only 4% or 1% per quarter we can expe

Arch Therapeutics (QB)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions